Aclaris Therapeutics, Inc. (ACRS) ownership: Top institutional holder: BML Capital Management, LLC ($53.44M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BML Capital Management, LLC | 14250000.00 | $53.44M | 2026-03-31 |
| Deep Track Capital, LP | 9345000.00 | $35.04M | 2026-03-31 |
| BlackRock, Inc. | 7407065.00 | $27.78M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 6804072.00 | $25.52M | 2026-03-31 |
| Vivo Capital, LLC | 6666666.00 | $25.00M | 2026-03-31 |
| VANGUARD GROUP INC | 6502080.00 | $19.57M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5167469.00 | $19.38M | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 4925374.00 | $18.47M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 |
Back to ACRS overview · ACRS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.